Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Annals of oncology

Results: 1-25/419

Citation: Cancer mortality up, life expectancy down in Eastern Europe, ANN ONCOL, 11(9), 2000, pp. 1073-1073

Citation: Tobacco companies tried to destroy WHO, ANN ONCOL, 11(9), 2000, pp. 1073-1074

Citation: Roche closes down prestigious institute, ANN ONCOL, 11(9), 2000, pp. 1074-1074

Citation: US administration halts cancer tests in Oklahoma, ANN ONCOL, 11(9), 2000, pp. 1074-1075

Citation: More money for the NHS: Will it work better?, ANN ONCOL, 11(9), 2000, pp. 1074-1074

Citation: Perhaps not everyone knows that ..., ANN ONCOL, 11(9), 2000, pp. 1075-1077

Authors: Costa, A
Citation: A. Costa, Breast cancer and the axilla: Not entirely out of the labyrinth, ANN ONCOL, 11(9), 2000, pp. 1079-1080

Authors: Newton, R
Citation: R. Newton, Infections and human cancer, ANN ONCOL, 11(9), 2000, pp. 1081-1082

Authors: Giuffrida, D Gharib, H
Citation: D. Giuffrida et H. Gharib, Anaplastic thyroid carcinoma: Current diagnosis and treatment, ANN ONCOL, 11(9), 2000, pp. 1083-1089

Authors: Franceschi, S
Citation: S. Franceschi, Strategies to reduce the risk of virus-related cancers, ANN ONCOL, 11(9), 2000, pp. 1091-1096

Authors: Gonzalez, R Silva, JM Sanchez, A Dominguez, G Garcia, JM Chen, XQ Stroun, M Provencio, M Espana, P Anker, P Bonilla, F
Citation: R. Gonzalez et al., Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: Follow-up study and prognostic significance, ANN ONCOL, 11(9), 2000, pp. 1097-1104

Authors: Engel, C Loeffler, M Schmitz, S Tesch, H Diehl, V
Citation: C. Engel et al., Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease, ANN ONCOL, 11(9), 2000, pp. 1105-1114

Authors: Kollmannsberger, C Nichols, C Meisner, C Mayer, F Kanz, L Bokemeyer, C
Citation: C. Kollmannsberger et al., Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: An explorative analysis using cart modeling, ANN ONCOL, 11(9), 2000, pp. 1115-1120

Authors: van Leeuwen, BL Kamps, WA Hartel, RM Veth, RPH Sluiter, WJ Hoekstra, HJ
Citation: Bl. Van Leeuwen et al., Effect of single chemotherapeutic agents on the growing skeleton of the rat, ANN ONCOL, 11(9), 2000, pp. 1121-1126

Authors: Ricci, S Antonuzzo, A Galli, L Ferdeghini, M Bodei, L Orlandini, C Conte, PF
Citation: S. Ricci et al., Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide, ANN ONCOL, 11(9), 2000, pp. 1127-1130

Authors: Escher, M Sappino, AP
Citation: M. Escher et Ap. Sappino, Primary care physicians' knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition, ANN ONCOL, 11(9), 2000, pp. 1131-1135

Authors: Greco, M Gennaro, M Valagussa, P Agresti, R Ferraris, C Ferrari, B Urban, C Gianni, L
Citation: M. Greco et al., Impact of nodal status on indication for adjuvant treatment in clinically node negative breast cancer, ANN ONCOL, 11(9), 2000, pp. 1137-1140

Authors: Lichtman, SM Niedzwiecki, D Barcos, M Carlisle, TL Cooper, MR Johnson, JL Peterson, BA
Citation: Sm. Lichtman et al., Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255, ANN ONCOL, 11(9), 2000, pp. 1141-1146

Authors: De Boer, RH Allum, WH Ebbs, SR Gui, GPH Johnston, SRD Sacks, NPM Walsh, G Ashley, S Smith, IE
Citation: Rh. De Boer et al., Multimodality therapy in inflammatory breast cancer: Is there a place for surgery?, ANN ONCOL, 11(9), 2000, pp. 1147-1153

Authors: Vassilomanolakis, M Koumakis, G Barbounis, V Demiri, M Pateras, H Efremidis, AP
Citation: M. Vassilomanolakis et al., Vinorelbine and cisplatin in metastatic breast cancer patients previously treated with anthracyclines, ANN ONCOL, 11(9), 2000, pp. 1155-1160

Authors: Sandler, AB Kindler, HL Einhorn, LH Mitchell, E Masters, G Kraut, M Nicol, S Raghavan, D
Citation: Ab. Sandler et al., Phase II trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastroesophageal junction, ANN ONCOL, 11(9), 2000, pp. 1161-1164

Authors: Ferry, DR Deakin, M Baddeley, J Daryanani, S Bramhall, S Anderson, DA Wakelam, MJO Doran, J Pemberton, G Young, AM Buckels, J Kerr, DJ
Citation: Dr. Ferry et al., A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: Correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints, ANN ONCOL, 11(9), 2000, pp. 1165-1170

Authors: Tavani, A Gallus, S La Vecchia, C Conti, E Montella, M Franceschi, S
Citation: A. Tavani et al., Aspirin and ovarian cancer: An Italian case-control study, ANN ONCOL, 11(9), 2000, pp. 1171-1173

Authors: Herod, J Burton, A Buxton, J Tobias, J Luesley, D Jordan, S Dunn, J Poole, CJ
Citation: J. Herod et al., A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versusradiotherapy alone in inoperable cancer of the cervix, ANN ONCOL, 11(9), 2000, pp. 1175-1181

Authors: Vaughan, MM Moore, J Riches, PG Johnston, SRD A'Hern, RP Hill, ME Eisen, T Ayliffe, MJ Thomas, JM Gore, ME
Citation: Mm. Vaughan et al., GM-CSF with biochemotherapy (cisplatin, DTIC, tamoxifen, IL-2 and interferon-alpha): A phase I trial in melanoma, ANN ONCOL, 11(9), 2000, pp. 1183-1189
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>